Ok Google, Start a Fire. IoT devices as witnesses and actors in fire investigations.

Fire incidents are amongst the most destructive events an investigator might encounter, completely transforming a scene with most of the objects left in ashes or highly damaged. Until now, fire investigations relied heavily on burn patterns and electrical artifacts to find possible starting locations, as well as witness statements and more recently witness imagery. As Internet of Things (IoT) devices, often seen as connected smart devices, become more common, the various sensors embedded within them provide a novel source of traces about the environment and events within. They collect and store information in different locations, often not touched by the event, such as remote servers (cloud) or companion smartphones, widening the investigation field for fire incidents. This work presents two controlled fire incidents in apartments that we furnished, equipped with IoT devices, and subsequently burnt. We studied the traces retrievable from the objects themselves after the incident, the companion smartphone apps, and the cloud and assessed the value of the information they conveyed. This research highlighted the pertinence to consider traces from IoT devices in the forensic process of fire investigation

Health state utilities associated with attributes of treatments for hepatitis C

BACKGROUND: Cost-utility analyses are frequently conducted to compare treatments for hepatitis C, which are often associated with complex regimens and serious adverse events. Thus, the purpose of this study was to estimate the utility associated with treatment administration and adverse events of hepatitis C treatments. DESIGN: Health states were drafted based on literature review and clinician interviews. General population participants in the UK valued the health states in time trade-off (TTO) interviews with 10- and 1-year time horizons. The 14 health states described hepatitis C with variations in treatment regimen and adverse events. RESULTS: A total of 182 participants completed interviews (50 % female; mean age = 39.3 years). Utilities for health states describing treatment regimens without injections ranged from 0.80 (1 tablet) to 0.79 (7 tablets). Utilities for health states describing oral plus injectable regimens were 0.77 (7 tablets), 0.75 (12 tablets), and 0.71 (18 tablets). Addition of a weekly injection had a disutility of −0.02. A requirement to take medication with fatty food had a disutility of −0.04. Adverse events were associated with substantial disutilities: mild anemia, −0.12; severe anemia, −0.32; flu-like symptoms, −0.21; mild rash, −0.13; severe rash, −0.48; depression, −0.47. One-year TTO scores were similar to these 10-year values. CONCLUSIONS: Adverse events and greater treatment regimen complexity were associated with lower utility scores, suggesting a perceived decrease in quality of life beyond the impact of hepatitis C. The resulting utilities may be used in models estimating and comparing the value of treatments for hepatitis C. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s10198-014-0649-6) contains supplementary material, which is available to authorized users